These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 26689065)

  • 21. Long-Term Analgesia following a Single Application of Fentanyl Transdermal Solution in Pigs.
    Goutchtat R; Chetboun M; Wiart JF; Gaulier JM; Pattou F; Allorge D; Hubert T
    Eur Surg Res; 2021; 62(2):115-120. PubMed ID: 34167112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transdermal fentanyl. A review of its pharmacological properties and therapeutic efficacy in pain control.
    Jeal W; Benfield P
    Drugs; 1997 Jan; 53(1):109-38. PubMed ID: 9010652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patterns of dosage changes with transdermal buprenorphine and transdermal fentanyl for the treatment of noncancer and cancer pain: a retrospective data analysis in Germany.
    Sittl R; Nuijten M; Poulsen Nautrup B
    Clin Ther; 2006 Aug; 28(8):1144-1154. PubMed ID: 16982291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Understanding transdermal buprenorphine and a practical guide to its use for chronic cancer and non-cancer pain management.
    O'Brien T; Ahn JS; Chye R; Le B; Lu H; Olarte G; Palladini M; Salti A; Shao YY; Yaakup H; Buemio KC; Colin CG; Hadjiat Y
    J Opioid Manag; 2019; 15(2):147-158. PubMed ID: 31343716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [No potentiation of fentanyl by use of transdermal buprenorphine in patients undergoing fast-track anesthesia for open-heart surgery].
    Freye E; Hartung E; Levy JV
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2006 Feb; 41(2):86-92. PubMed ID: 16493560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Equipotent doses to switch from high doses of opioids to transdermal buprenorphine.
    Mercadante S; Casuccio A; Tirelli W; Giarratano A
    Support Care Cancer; 2009 Jun; 17(6):715-8. PubMed ID: 19104845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gastrointestinal symptoms under opioid therapy: a prospective comparison of oral sustained-release hydromorphone, transdermal fentanyl, and transdermal buprenorphine.
    Wirz S; Wittmann M; Schenk M; Schroeck A; Schaefer N; Mueller M; Standop J; Kloecker N; Nadstawek J
    Eur J Pain; 2009 Aug; 13(7):737-43. PubMed ID: 18977159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Opioids switching with transdermal systems in chronic cancer pain.
    Aurilio C; Pace MC; Pota V; Sansone P; Barbarisi M; Grella E; Passavanti MB
    J Exp Clin Cancer Res; 2009 May; 28(1):61. PubMed ID: 19422676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term management of chronic pain with transdermal buprenorphine: a multicenter, open-label, follow-up study in patients from three short-term clinical trials.
    Likar R; Kayser H; Sittl R
    Clin Ther; 2006 Jun; 28(6):943-52. PubMed ID: 16860176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transdermal fentanyl compared with parenteral buprenorphine in post-surgical pain in swine: a case study.
    Harvey-Clark CJ; Gilespie K; Riggs KW
    Lab Anim; 2000 Oct; 34(4):386-98. PubMed ID: 11072859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is the use of transdermal fentanyl inappropriate according to the WHO guidelines and the EAPC recommendations? A study of cancer patients in Italy.
    Ripamonti C; Fagnoni E; Campa T; Brunelli C; De Conno F
    Support Care Cancer; 2006 May; 14(5):400-7. PubMed ID: 16485087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors influencing quality of life in cancer patients: the role of transdermal fentanyl in the management of pain.
    Payne R
    Semin Oncol; 1998 Jun; 25(3 Suppl 7):47-53. PubMed ID: 9671331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel approach to pharmaco-EEG for investigating analgesics: assessment of spectral indices in single-sweep evoked brain potentials.
    Gram M; Graversen C; Nielsen AK; Arendt-Nielsen T; Mørch CD; Andresen T; Drewes AM
    Br J Clin Pharmacol; 2013 Dec; 76(6):951-63. PubMed ID: 23521205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transdermal buprenorphine in cancer pain and palliative care.
    Sittl R
    Palliat Med; 2006; 20 Suppl 1():s25-30. PubMed ID: 16764218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transdermal buprenorphine (Butrans) for chronic pain.
    Med Lett Drugs Ther; 2011 Apr; 53(1362):31-2. PubMed ID: 21502936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transdermal buprenorphine controls central neuropathic pain.
    Weiner M; Sarantopoulos C; Gordon E
    J Opioid Manag; 2012; 8(6):414-5. PubMed ID: 23264319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transdermal buprenorphine in clinical practice--a post-marketing surveillance study in 13,179 patients.
    Griessinger N; Sittl R; Likar R
    Curr Med Res Opin; 2005 Aug; 21(8):1147-56. PubMed ID: 16083522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Transdermal buprenorphine during pregnancy].
    Ebner E; Wiedmann M
    Schmerz; 2006 Aug; 20(4):334-7. PubMed ID: 16283207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analgesic effect of switching from oral opioids to a once-a-day fentanyl citrate transdermal patch in patients with lung cancer.
    Takakuwa O; Oguri T; Maeno K; Yokoyama M; Hijikata H; Uemura T; Ozasa H; Ohkubo H; Miyazaki M; Niimi A
    Am J Hosp Palliat Care; 2013 Nov; 30(7):726-9. PubMed ID: 23264661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transdermal fentanyl: new preparation. An alternative to morphine.
    Prescrire Int; 1998 Oct; 7(37):137-40. PubMed ID: 10915416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.